Form 4 for CLPT ClearPoint Neuro, Inc.
Accepted 2026-04-02 14:52:06 ET · period of report 2026-04-01 · accession 0001193125-26-139783 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-02 14:52 | 2026-04-01 | CLPT | Girin Pascal E R | Dir | A - Grant | $9.10 | +755 | 98.2K | +0.8% | +$6,870 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-01 | A | A | 755 | $9.10 | 98,206 | D | — | — | (F1) These shares were issued pursuant to the issuer's Sixth Amended and Restated 2013 Incentive Compensation Plan, in payment of fees owed to the reporting person under the issuer's Non-Employee Director Compensation Plan, as amended and restated. The shares were issued at the closing price of the issuer's common stock at March 31, 2026. |